Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia

Published:2015-05-20 Issue:5 Volume:10 Page:e0127637
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kuželová Kateřina,Brodská Barbora,Fuchs Ota,Dobrovolná Marie,Soukup Petr,Cetkovský Petr

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Mutational landscape of AML with normal cytogenetics: biological and clinical implications;MP Martelli;Blood Rev,2013

2. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization;L Federici;Protein Sci,2013

3. Nucleophosmin in acute myelogenous leukemia;M Nakagawa;N Engl J Med,2005

4. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML;B Falini;Blood,2006

5. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype;B Falini;N Engl J Med,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frameshift Mutations in Leukemia-Associated Genes Correlate With Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia;Journal of Hematology;2024-06

2. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2023-07

3. Current status and future perspectives in targeted therapy of NPM1-mutated AML;Leukemia;2022-08-25

4. Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine;Science Translational Medicine;2022-06-15

5. NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia;OncoImmunology;2022-05-06